Breakthrough in Green and Economical Synthesis of Key GLP-1 Intermediate
At Hiray Pharma Solutions, our R&D team continues to deepen process innovation around key intermediates of next-generation metabolic drugs. Today, we are pleased to share progress on a more efficient and industrially viable synthesis of (4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride, a crucial intermediate of Eli Lilly’s oral GLP-1 candidate Orforglipron.*What We Improved The original patented route relies on a palladium-catalyzed Buchwald coupling — effective, but costly and less suitable for large-scale industrial adoption.Our team developed an improved pathway by replacing Pd catalysts with a cost-effective copper-catalyzed Ullmann reaction, achieving both scalability and economic advantage.* Key Technical Highlights✔ Copper bromide (CuBr2) used as catalyst— Avoids catalyst oxidation poisoning often seen with Cu salts— Delivers 80% overall yield of the target hydrazine intermediate✔ Ligand engineering for catalytic efficiency— A redox-active pyrrolyl hydrazide ligand enables Cu(II)/Cu(III) catalytic cycling— Facilitates smooth oxidative addition and C–N bond formation✔ Significant cost reductionReplacing palladium acetate with inexpensive copper bromide greatly improves competitiveness for commercial-scale production.*Process Optimization Results1. Hydrazine hydrate equivalentsIncreasing hydrazine equivalents elevated compound purity from 86.4% → 94.3%. 2. Catalyst screeningCuBr and CuI demonstrated superior performance, giving >92% purity of the desired product. 3. Solvent selectionDMSO proved optimal and robust for scale-up, outperforming alternative solvents such as isopropyl acetate, t-butanol, and Me-THF. *Why This MattersOrforglipron represents a promising direction in non-peptide oral GLP-1 therapies. By optimizing upstream intermediates with scalable, cost-competitive synthesis routes, Hiray Pharma strengthens its position as a dependable partner for global pharmaceutical development and manufacturing. We will continue investing in innovation that accelerates high-quality, industrially robust API and intermediate supply for partners worldwide.